Search

everythinglearnresearchcommunity

for

Search:↓

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Large prostates link to more hair loss.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

New treatments for male hypogonadism are effective and should be personalized.

A man developed hair loss from testosterone treatment but improved with additional medication.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

A rare ovarian tumor can occur without causing male-like symptoms.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Steroid cell tumors in the ovary are rare, can produce testosterone causing symptoms, and are mainly treated with surgery.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Finasteride improves hair but may reduce sperm quality at higher doses.

Finasteride 1 mg/day reduces semen quality without affecting hormones or sexual function.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.